Key result
ONKOger model identifies geriatric vulnerability in ~79% of older breast cancer patients, prompting treatment modifications.
Why the study?
Does the ONKOger model (integrating Comprehensive Geriatric Assessment and cardio-oncology) improve individualized treatment planning in older breast cancer patients?
Observational (n=832)
No
Does the ONKOger model (integrating Comprehensive Geriatric Assessment and cardio-oncology) improve individualized treatment planning in older breast cancer patients?
Answers are grounded in this paper and cite their sources.
The implementation of an integrated oncogeriatric model, including cardio-oncology assessment, is feasible and leads to clinically relevant treatment modifications in older breast cancer patients.
Introduction. Older women constitute a growing proportion of breast cancer patients, yet their care often remains fragmented and insufficiently adapted to functional status. To address this gap, the first onco-geriatric unit in Poland was established within a comprehensive breast cancer center. Material and methods. The ONKOger model integrates routine Comprehensive Geriatric Assessment (CGA), cardio-oncology consultation, and multidisciplinary treatment planning. A pilot phase was conducted in women aged ≥ 75 years, assessing feasibility, geriatric impairments and the impact on treatment decisions. Results. Among 832 patients evaluated, 138 (16.6%) were aged ≥ 75 years, 109 (79%) screened positive for vulnerability (VES-13 ≥ 3). CGA frequently identified multimorbidity, polypharmacy, functional decline and unmet social needs. Treatment plans were modified in a substantial proportion, including dose adjustments, simplified systemic therapy and enhanced supportive care. Conclusions. The ONKOger model is feasible, clinically relevant and supports individualized treatment and safer care pathways for older breast cancer patients. It may serve as a foundation for developing structured oncogeriatric services in Poland.
No takes yet. Share an insight, caveat, or question.
Konieczna et al. (2026) conducted an observational in Breast cancer (n=832). ONKOger model (integrated oncogeriatric care pathway) was evaluated on Development and validation of an integrated oncogeriatric diagnostic and therapeutic pathway. The ONKOger pilot program identified geriatric vulnerability in 79% of breast cancer patients aged 75 years and older, leading to clinically relevant modifications of oncological treatment plans.
Synapse has enriched 10 related papers. Consider them for comparative context: